Would an IASLC Mid-Career Grant Be Helpful to You and Your Career Path?
International Association for the Study of Lung Cancer shared on LinkedIn:
” ‘We expect this translational research to validate the immunogenicity of an ALK-specific vaccine in humans, identify drivers of vaccine response, and assess surrogate biologic endpoints critical for regulatory development.
This approach could shift the MRD state toward cure in advanced ALK+ lung cancer and establish an immunogenomic framework to accelerate vaccine and immunotherapy development in other oncogene-driven lung cancers (e.g., EGFR, BRAF, ROS1, RET).
The IASLC Career Advancement Grant will enable the acquisition of the critical preliminary data required for subsequent major funding and my continued advancement towards becoming an independent researcher.’
– Vincent Lam
Would an IASLC Mid-Career Grant be helpful to you and your career path? Keep an eye out for our next round of applications opening soon.”
More posts featuring IASLC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023